Amarantus BioScience Holdings, Inc.

AMBS · OTC
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Assets
Cash & Equivalents$0$0$0$0
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$31$31$31$31
Total Curr. Assets$31$31$31$31
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$1$1$1$1
Long-Term Investments$10,184$10,176$11,521$11,124
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$10,185$10,177$11,522$11,125
Other Assets$0$0$0$0
Total Assets$10,216$10,208$11,553$11,156
Liabilities
Payables$15,369$15,309$15,249$15,197
Short-Term Debt$19,124$19,139$19,149$19,141
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$424$424$424$423
Total Curr. Liab.$34,918$34,873$34,822$34,761
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$34,918$34,873$34,822$34,761
Equity
Pref Stock$1,533$1,533$1,533$1,533
Common Stock$298$293$291$291
Retained Earnings-$106,526-$106,474-$105,069-$105,405
AOCI-$298-$293-$291-$291
Other Equity$80,291$80,276$80,266$80,266
Total Equity-$24,702-$24,665-$23,269-$23,606
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,216$10,208$11,553$11,156
Net Debt$19,124$19,139$19,149$19,141